Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000905148-25-003777
Filing Date
2025-11-05
Accepted
2025-11-05 16:06:41
Documents
1
Period of Report
2025-11-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4/A  
1 form4.xml 4/A 3473
  Complete submission text file 0000905148-25-003777.txt   5194
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27713 248-681-9815
Opus Genetics, Inc. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 37000 GRAND RIVER AVE SUITE 120 FARMINGTON HILLS MI 48335
Business Address
Magrath George (Reporting) CIK: 0001999390 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34079 | Film No.: 251453919